Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

National Institute for Health and Care Excellence NICE logo

NICE backs two advanced breast cancer drugs after price cuts

An estimated 8,000 women will be eligible to receive the drugs due to discounts

- PMLiVE

AbbVie named PMEA 2017 Company of the Year

Sees off strong competition from Amgen and Sanofi

- PMLiVE

The EarthWorks wins PMEA Support Agency of the Year

Edges out Complete Medical Communications and Makara Health to take the title

- PMLiVE

The state of trust

Roche’s Future-proofing Healthcare event shows  how the current model is a complicated one

AstraZeneca AZ

AZ prices severe asthma drug Fasenra below competition

The discounted drug will cost $38,000 in the first year

- PMLiVE

Loxo’s cancer drug pair attracts $1.5bn deal with Bayer

The German pharma group will gain full rights to the drugs outside the US

- PMLiVE

Shire wins CHMP backing for Adynovi

Haemophilia A treatment backed for European approval

- PMLiVE

Ann Barbier joins Translate Bio as its chief medical officer

She will take responsibility for leading the US biotech's clinical R&D

Orion appoints VP of oncology, R&D

Professor Heikki Joensuu joins from Helsinki University Hospital

- PMLiVE

Adding value in emerging markets

What benefit do branded generics bring to patients around the world?

- PMLiVE

A new picture

Changing the route to brand growth

- PMLiVE

Another well-deserved promotion at Porterhouse Medical

We are delighted to announce the promotion of one of our scientific staff, Emma, to the role of senior medical writer. Not only was Emma the winner of our 2016 Entrepreneur...

Porterhouse Medical Group

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links